helium-3

Small moleculeexperimental

Helium-3 is a light, stable isotope of helium with two protons and one neutron. Helium-3 and hydrogen-1 are the only stable nuclides with more protons than neutrons. It was discovered in 1939. Helium-3 atoms are fermionic and become a superfluid at the temperature of 2.491 mK. — Wikipedia

Clinical trial activity

5 trials · 5 clinical orgs · 0 marketing orgs

Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0

Earliest trial started Nov 1, 2008 (NCT00846287)

Timeline

2010s

  1. Jan 1, 2010

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetUnclear

    unclear

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • helium-3
  • helium-3
  • helium-3
  • helium he-3
  • helium he-3
  • helium, he-3
  • helium, he-3

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT02783768Phase 1Mar 1, 2017Columbia University
NCT02163681N/AJan 1, 2011University of Virginia, Xemed LLC
NCT02026531Phase 1/Phase 2 (Phase 2)Nov 30, 2010Sheffield Hallam University
NCT00846287N/ANov 1, 2008University of Massachusetts
NCT00846573N/ANov 1, 2008University of Massachusetts
Showing 5 of 5 trials
Page 1 / 1

Organizations

Research & Development (5)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
University of MassachusettsAcademic/Hospital2212008
Columbia UniversityAcademic/Hospital1112017
Sheffield Hallam UniversityAcademic/Hospital1112010
University of VirginiaAcademic/Hospital1112011
Xemed LLCFor profit1012011
5 organizations
Page 1 / 1